Gimv
gimv.com Direct + LP
Gimv is a European investment company listed on Euronext Brussels. It invests directly in companies through four sector platforms and also offers long-term equity investments through its Anchor Investments pillar.
Gimv is a private equity firm headquartered in Antwerp, Belgium. It invests both directly in companies and in funds as a limited partner, from growth to buyout, in consumer, healthcare, smart Industries and sustainable Cities. Its stated cheque size is EUR 20 up to EUR 100 million (platforms); EUR 50 up to 400 million (anchor). 2.1 billion EUR portfolio value under management and 63 portfolio companies, as it reports.
“Gimv is a European investment company, listed on Euronext Brussels. As a recognized market leader, we partner with entrepreneurial and innovative companies in 4 forward-looking investment areas.”
— Gimv, own website
- Layer
- Direct + LP
- Type
- Private equity
- Invests in
- Benelux, France, DACH
- Sectors
- Consumer, Healthcare, Smart Industries, Sustainable Cities
- Cheque size
- EUR 20 up to EUR 100 million (platforms); EUR 50 up to 400 million (anchor)
- Assets under management
- 2.1 billion EUR portfolio value
- Portfolio
- 63 companies
Team, as Gimv publishes it
- Bart Troubleyn Managing Partner - Head Anchor Investments
- Floris van Halder Partner - Gimv Anchor Investments
- Karel Vermeulen Investment Manager (*seconded by WorxInvest)
- Michiel Van Leemput Associate
- Karolien Fieremans Investment Controlling Director
- Aline Loots Multiplatform Analyst
- Jacob Leenknecht Multiplatform Analyst
- Patricia Heymans Management Assistant
Names and roles exactly as listed on gimv.com. Nothing else about these people is recorded.
Co-invests most often with
Derived from portfolio pages both investors publish themselves: each pair below lists at least one company in common. 26 co-investors found.
- BioGeneration Ventures 2 shared companies: kivubioscience.com, complementtx.com
- BOM (Brabantse Ontwikkelings Maatschappij) 2 shared companies: kivubioscience.com, bioconnection.eu
- Mission BioCapital 2 shared companies: immunostherapeutics.com, mediartx.com
- Andera Partners 2 shared companies: fire1foundry.com, exciva.com
- Sofinnova 1 shared company: biotalys.com
- INKEF Capital 1 shared company: onwd.com
- Runway Growth Capital LLC 1 shared company: onwd.com
- HealthCap 1 shared company: kivubioscience.com
- M Ventures 1 shared company: kivubioscience.com
- Double Point Ventures 1 shared company: immunostherapeutics.com
and 16 more — the graph.
Where this comes from
Every fact above was read from a page Gimv publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.
- https://www.gimv.com/enname, is_investor, hq_country, hq_city, invests_in_geographies, stage_min, stage_max, cheque_size, thesis_quote, thesis_quote_page, description, aum, portfolio_count, status, confidence
- https://www.gimv.com/en/about-gimvlayer, type
- https://www.gimv.com/en/investment-platformssectors
- https://www.gimv.com/en/anchor-investmentspeople
Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.
Record 1237 · added 2026-08-28 · link last verified 2026-09-06 · confidence high
Similar investors
- ApheonPrivate equity · Growth – Buyout · Brussels, Belgium
- Groupe Bruxelles Lambert (GBL)Private equity · Growth – Buyout · Brussels, Belgium
- Strada PartnersPrivate equity · Growth – Buyout · Antwerp, Belgium
- FincoPrivate equity · Growth – Buyout · Antwerp, Belgium
- Junction Growth InvestorsPrivate equity · Growth – Buyout · Antwerp, Belgium
- Sofindev Management N.V.Private equity · Growth – Buyout · Diegem, Belgium